Laura Sutcliffe
Stock Analyst at Citigroup
(0.44)
# 4,200
Out of 5,174 analysts
11
Total ratings
27.27%
Success rate
-13.02%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Laura Sutcliffe
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TLX Telix Pharmaceuticals | Maintains: Buy | $22 → $23 | $8.77 | +156.56% | 4 | Feb 24, 2026 | |
| RMD ResMed | Maintains: Buy | $330 → $345 | $228.19 | +51.19% | 4 | Feb 2, 2026 | |
| ARGX argenx SE | Initiates: Buy | $390 | $677.50 | -42.44% | 1 | Jun 18, 2021 | |
| GLPG Galapagos NV | Downgrades: Neutral | n/a | $29.80 | - | 2 | Dec 20, 2019 |
Telix Pharmaceuticals
Feb 24, 2026
Maintains: Buy
Price Target: $22 → $23
Current: $8.77
Upside: +156.56%
ResMed
Feb 2, 2026
Maintains: Buy
Price Target: $330 → $345
Current: $228.19
Upside: +51.19%
argenx SE
Jun 18, 2021
Initiates: Buy
Price Target: $390
Current: $677.50
Upside: -42.44%
Galapagos NV
Dec 20, 2019
Downgrades: Neutral
Price Target: n/a
Current: $29.80
Upside: -